Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Quality Index
Jiangsu Aidea Pharmaceutical Co Ltd cash flow quality index. Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Quality Index of 2.55x as of March 2025. Operating cash flow of CN¥39.75 Million exceeds net income of CN¥15.58 Million, indicating high earnings quality where cash backs reported profits. Explore Jiangsu Aidea Pharmaceutical Co Ltd (688488) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Cash flow quality index of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2020. Historical Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 688488 net asset quality score to measure how much of total assets are equity-financed.
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2016–2020)
Jiangsu Aidea Pharmaceutical Co Ltd cash flow quality index by year from 2016 to 2020. Year-by-year earnings quality comparison for Jiangsu Aidea Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Jiangsu Aidea Pharmaceutical Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.41x | CN¥56.17 Million | CN¥39.77 Million | ▼ -15.4% |
| 2019 | 1.67x | CN¥56.20 Million | CN¥33.65 Million | ▲ +143.0% |
| 2018 | -3.89x | CN¥-33.50 Million | CN¥8.62 Million | ▼ -276.9% |
| 2016 | 2.20x | CN¥31.29 Million | CN¥14.24 Million | — |